GlassScriptPhysician profile
Neil Kaushal
NPI 1275943110
$24,262.89
in general payments reported to CMS, 2019-2025
13 companies · $2,733 in 2025
The $2,733 reported for 2025 was more than what 84% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,439 · 2020: $1,377 · 2021: $1,587 · 2022: $1,294 · 2023: $8,331 · 2024: $5,502 · 2025: $2,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Travel and Lodging: $3,834 · Food and Beverage: $3,503 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Travel and Lodging | $3,833.84 |
| Food and Beverage | $3,503.06 |
| Education | $228.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $19,321.93 | 2019-2025 | Everest Spinal System, Airo, Xia 3 |
| Vb Spine LLC | $2,479.04 | 2025 | Everest Spinal System, Prolift, Xia 3 |
| Zimmer Biomet Holdings, INC. | $709.18 | 2019-2021 | |
| Alphatec Spine, INC | $486.32 | 2022-2025 | Other - Miscellaneous, Invictus Open |
| Medtronic USA, INC. | $423.71 | 2019 | |
| Nuvasive, INC. | $358.92 | 2021-2022 | |
| Smith+Nephew, INC. | $172.42 | 2019 | |
| Stability Biologics, LLC | $86.74 | 2020 | |
| Depuy Synthes Sales INC. | $85.29 | 2021 | |
| Zimvie INC. | $72.22 | 2022 | |
| Medicrea USA, Corp. | $31.40 | 2020 | |
| Orthofix Medical, INC. | $21.67 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Kaushal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.